Supplementary Data from Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma

Supplementary Data Supplementary Table S1.Clinical pathological parameters of enrolled patients Supplementary Table S2. The sample information of QuantiGenePlex RNA assay Supplementary Table S3. Correlation of CDK4 pathway aberrations withPD-L1 protein expression in melanoma patients.